[Remainderof page intentionally left blank; signature page to follow.]

EX-10.3 4 s103305_ex10-3.htm EXHIBIT 10-3

 

Exhibit 10.3

 

CB Pharma Acquisition Corp.

3 Columbus Circle, 15th Floor

New York, New York 10019

Attention: Lindsay A. Rosenwald

 

EJF Opportunities, LLC

Stephen B. Pudles

Jose M. Aldeanueva

Jeffrey J. Gutovich Profit Sharing Plan

Barry Rodgers

 

Dear Sirs:

 

Pursuant to that certain Registration Rights Agreement (the “RRA”), dated as of December 12, 2014, by and among CB Pharma Acquisition Corp., a Cayman Islands company (the “Company”), and the respective undersigned parties (each, individually, a “Shareholder”, and collectively, the “Shareholders”), the Company has granted the Shareholders certain registration rights (the “Registration Rights”) with respect to the ordinary shares of the Company (the “Insider Shares”) purchased by the Shareholders from the Company prior to the Company’s initial public offering.

 

The Shareholders have executed an agreement (the “Transfer Agreement”) of even date herewith pursuant to which the Shareholders have transferred the Insider Shares, for aggregate consideration of $1.00, to EJF Opportunities, LLC, Stephen B. Pudles, Jose M. Aldeanueva, Jeffrey J. Gutovich Profit Sharing Plan and Barry Rodgers (the “Investors”), in the amounts identified in Schedule A.  In connection with the transfer of the Insider Shares, the Shareholders desire to assign their Registration Rights with respect to the Insider Shares to the Investors in accordance with Section 6.2 of the RRA, and the Company has agreed to consent to such assignment. Accordingly, the Shareholders’ Registration Rights with respect to such securities shall be assigned to the Investors as of the date hereof.  The Shareholders shall maintain their Registration Rights with respect to any other securities of the Company not transferred to the Investors pursuant to the Transfer Agreement.  

 

[Remainder of page intentionally left blank; signature page to follow.]

 

 

 

 

 

 

  Very truly yours,  
     
  SHAREHOLDERS:  
     
  /s/ Lindsay A. Rosenwald  
  Fortress Biotech, Inc.  
     
  /s/ Adam J. Chill  
  Adam J. Chill  
     
  /s/ Arthur A. Kornlbuth  
  Arthur A. Kornlbuth  
     
  /s/ Neil Herskowitz  
  Neil Herskowitz  

 

The undersigned acknowledges and consents to the foregoing terms.

 

COMPANY:

 

CB PHARMA ACQUISITION CORP.

 

By: /s/ Lindsay A. Rosenwald  
  Name: Lindsay A. Rosenwald  
  Title: Chief Executive Officer  

 

[Signature Page - Registration Rights Assignment Letter]

 

 

 

 

Schedule A

 

Name of Shareholder        Escrow Shares being
Transferred
  Transferee
         
Fortress Biotech, Inc.   520,000   EJF Opportunities, LLC
         
Fortress Biotech, Inc.   260,000   Stephen B. Pudles
         
Fortress Biotech, Inc.   130,000   Jose M. Aldeanueva
         
Fortress Biotech, Inc.   110,000   Jeffrey J. Gutovich Profit Sharing Plan
         
Adam J. Chill   10,000   Jeffrey J. Gutovich Profit Sharing Plan
         
Arthur A. Kornbluth   10,000   Jeffrey J. Gutovich Profit Sharing Plan
         
Neil Herskowitz   10,000   Barry Rodgers